Skip to main content
OpenTrials
Completed

NCT Number: NCT03733899

An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens Discomfort

This is a controlled, randomized, subject-masked, 3x3 crossover, non-dispensing, contralateral study. Twenty subjects will be recruited based on their scores (with their habitual lenses) from the Contact Lens Dry Eye Questionnaire-8 and examined on four occasions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Manchester

Manchester, M13 9PL, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • They are of legal age (18 years) and capacity of volunteer.
  • The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • They must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • They have worn the same brand of soft spherical contact lenses for at least the previous three months, by self-report.
  • They are defined as 'symptomatic' contact lens wearers (CLDEQ-8 score of 20-37) with their habitual contact lenses.
  • They are willing to wear their lenses for approximately 14 hours on study days.
  • They have a wearable pair of spectacles, if applicable.
  • They agree not to participate in other clinical research for the duration of this study.
  • They can attain high contrast logMAR visual acuity of 0.20 or better in their habitual contact lenses in each eye.

Exclusion criteria

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • They have an ocular disorder, which would normally contra-indicate contact lens wear.
  • They have a systemic disorder, which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They have had cataract or corneal refractive surgery.
  • They are pregnant or breast-feeding by self-report.
  • They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease (e.g. HIV), by self-report.
  • They have any known hypersensitivity or allergic reaction to any of the known ingredients in the anesthetic.
  • They have a history of severe allergic reaction or anaphylaxis.
  • They have a history of cardiac disease or hyperthyroidism.
  • They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
  • They are an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They have grade 3 or greater of any of the following ocular surface signs which would contraindicate contact lens wear: corneal edema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.

Treatment and study plan

Local Anesthesia

Diagnostic Test

Minims Proxymetacaine hydrochloride Eye Drops

Placebo

Diagnostic Test

Sodium Chloride Solution

Primary outcomes

  1. Subjective Comfort Scores

    Time frame: 5 and 10 Minutes post-treament

    Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.

  2. Change in Subjective Comfort Scores From Pre-treatment to Post-treatment

    Time frame: 14-Hours upon Lens-Insertion (pre-treatment), and 10 Minutes post-treament

    Subjects were asked to rate how comfortable each eye was overall using a visual analog scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable. Subjects wore their habitual contacts during the pre-treatment assessment.

  3. Subjective Comfort Score Difference Between Post-treatment and Post-insertion Within Anesthetic

    Time frame: Immediately after lens-insertion, 5 and 10 minutes post-treatment

    Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.

Secondary outcomes

  1. Change in Subjective Comfort Between Ocular Regions at Posttreatment Within Anesthetic

    Time frame: 5 and 10 minutes post treatment

    Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.

  2. Change in Subjective Comfort From Pre-treatment to Post-Treatment Between Ocular Regions

    Time frame: 14 hours upon lens-insertion (pre-treatment), 5- and 10- minutes post-treatment

    Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.

  3. Subjective Comfort Difference Between Post-removal and Preinsertion Within Anesthetic and Cornea

    Time frame: Immediately before lens-insertion (pre-insertion), 30 seconds after lens removal

    Subjects were asked to rate how comfortable each eye was overall on the scale of 0 to 100 where 0=worse comfort imaginable and 100=best comfort imaginable.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Vision Care, Inc.

Industry

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Nov 7, 2018
Registry last updated
Apr 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.